Pathogenetic mechanisms and treatment principles of chronic thromboembolic pulmonary hypertension

被引：0
|
作者：
Shostak, N. A. [1 ]
Klimenko, A. A. [1 ]
Demidova, N. A. [1 ]
Novikov, I. V. [1 ]
机构：
[1] Russian State Med Univ, Ostrovitjanova 1, Moscow 117997, Russia
来源：
RATIONAL PHARMACOTHERAPY IN CARDIOLOGY | 2011年 / 7卷 / 02期
关键词：
pulmonary hypertension; chronic thromboembolic pulmonary hypertension; thromboembolism of pulmonary artery; thromboendarterectomy; bosentan; prostacyclin analogues; phosphodiesterase-5; inhibitors;
D O I：
10.20996/1819-6446-2011-7-2-199-203
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Data about chronic thromboembolic pulmonary hypertension (CTPH) prevalence is presented. The main CTPH clinical manifestations are described. The possible reasons and pathogenetic mechanisms of CTPH development are discussed. Features of unfavorable disease prognosis are also presented. Indications, results, limitations for CTPH surgical treatment are shown. Data of the currently completed clinical studies on bosentan, prostacyclin analogues and phosphodiesterase-5 inhibitors usage in CTPH are presented.
引用
收藏
页码：199 / 203
页数：5
相关论文
共 50 条
  • [1] PATHOGENETIC MECHANISMS IN CHRONIC PULMONARY-HYPERTENSION
    HUREWITZ, AN
    BERGOFSKY, EH
    HEART & LUNG, 1986, 15 (04): : 327 - 335
  • [2] Treatment of Chronic Thromboembolic Pulmonary Hypertension
    Wiedenroth, Christoph B.
    Mayer, Eckhard
    Guth, Stefan
    AKTUELLE KARDIOLOGIE, 2023, 12 (01) : 34 - 38
  • [3] Pulmonary endarterectomy for the treatment of chronic thromboembolic pulmonary hypertension
    Guth, Stefan
    Wiedenroth, Christoph B.
    Kramm, Thorsten
    Mayer, Eckhard
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2016, 10 (06) : 673 - 684
  • [4] MECHANISMS OF HYPOXEMIA IN CHRONIC THROMBOEMBOLIC PULMONARY-HYPERTENSION
    KAPITAN, KS
    BUCHBINDER, M
    WAGNER, PD
    MOSER, KM
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1989, 139 (05): : 1149 - 1154
  • [5] Chronic thromboembolic pulmonary hypertension: Diagnosis and treatment
    Shure, D
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 17 (01) : 7 - 15
  • [6] CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION DRUG TREATMENT
    Ivanov, S. N.
    Chernyavsky, A. M.
    Edemsky, A. G.
    Vasiltseva, O. Ya.
    KARDIOLOGIYA, 2024, 64 (12) : 77 - 85
  • [7] Advances in treatment of chronic thromboembolic pulmonary hypertension
    Tzoumas, Andreas
    Peppas, Spyridon
    Sagris, Marios
    Papanastasiou, Christos A.
    Barakakis, Paraschos Archontakis
    Bakoyiannis, Christos
    Taleb, Adam
    Kokkinidis, Damianos G.
    Giannakoulas, George
    THROMBOSIS RESEARCH, 2022, 212 : 30 - 37
  • [8] Surgical treatment of chronic thromboembolic pulmonary hypertension
    Mayer, Eckhard
    SWISS MEDICAL WEEKLY, 2006, 136 (31-32) : 491 - 497
  • [9] Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
    Ghofrani, Hossein-Ardeschir
    D'Armini, Andrea M.
    Grimminger, Friedrich
    Hoeper, Marius M.
    Jansa, Pavel
    Kim, Nick H.
    Mayer, Eckhard
    Simonneau, Gerald
    Wilkins, Martin R.
    Fritsch, Arno
    Neuser, Dieter
    Weimann, Gerrit
    Wang, Chen
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (04): : 319 - 329
  • [10] Chronic thromboembolic pulmonary hypertension: Medical treatment
    Ozsu, Savas
    Cinarka, Halit
    PULMONARY CIRCULATION, 2013, 3 (02) : 341 - 344
12345